Sign in
Open labeled pilot study of thalidomide (THAL) as a novel therapy for medically resistant ulcerative colitis (UC)
Journal article   Peer reviewed

Open labeled pilot study of thalidomide (THAL) as a novel therapy for medically resistant ulcerative colitis (UC)

L.Y Kam, E.A Vasiliauskas, M.T Abreu, P.V Hassard, J Zeldis and S.R Targan
Digestive and liver disease, Vol.32, pp.A48-A48
2000-05

Metrics

5 Record Views

Details